Long intergenic non-protein coding RNA 2101 (LINC02101)

Long intergenic non-protein coding RNA 2101 (LINC02101) is a member of the long intergenic non-coding RNA (lincRNA) family, characterized by being longer than 200 nucleotides and transcribed from regions of the genome that do not overlap with protein-coding genes[1][3][5]. LincRNAs, including LINC02101, are part of the broader long non-coding RNA (lncRNA) group and are thought to regulate gene expression through mechanisms such as chromatin remodeling, transcriptional regulation, and RNA stabilization[1]. While many lincRNAs serve as fine-tuners of the expression of neighboring or distant genes, only a small fraction have been functionally characterized, and LINC02101 currently lacks direct evidence linking it to specific biological pathways or disease processes[1][3][5]. There is no information supporting its classification as a therapeutic target (such as a receptor, enzyme, or transporter), nor are there known drugs that directly target this RNA or its product[1][3][5].

Other names

CTD-2037L6.2LINC02101